Please enable JavaScript to continue using this application.

Compare $FENC vs $IRD | Chartloom

Compare

$FENC vs $IRD

Fennec Pharmaceuticals Inc · Opus Genetics Inc

FENC

Fennec Pharmaceuticals Inc

IRD

Opus Genetics Inc

Compare $FENC vs $IRD

Comparing Fennec Pharmaceuticals Inc and Opus Genetics Inc

FENCFennec Pharmaceuticals Inc

IRDOpus Genetics Inc

FENCFennec Pharmaceuticals Inc

Market cap

$372M

P/E (TTM)

—

Forward P/E (NTM)

18.55x

Forward P/S (NTM)

4.23x

Rev growth (TTM)

77.8%

YTD performance

39.5%

52W performance

16.2%

FCF yield

-0.5%

IRDOpus Genetics Inc

Market cap

$384M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

28.68x

Rev growth (TTM)

-36.1%

YTD performance

119.3%

52W performance

126.8%

FCF yield

-10.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FENC

IRD

Detailed metrics comparison

FENC

Fennec Pharmaceuticals Inc

IRD

Opus Genetics Inc

Market Cap

FENC$372M

IRD$384M

Enterprise Value

FENC$331M

IRD$331M

Price

FENC$10.71

IRD$4.65

P/E Ratio

FENCN/A

IRDN/A

P/S Ratio

FENC6.28x

IRD38.96x

EV/Sales

FENC5.59x

IRD33.62x

EV/EBITDA

FENC111.97x

IRD11.29x

P/B Ratio

FENC8.43x

IRD24.83x

P/FCF Ratio

FENCN/A

IRDN/A

EV/FCF

FENC-162.16x

IRD-8.15x

PEG Ratio

FENCN/A

IRDN/A

Forward P/E (NTM)

FENC18.55x

IRDN/A

Forward P/S (NTM)

FENC4.23x

IRD28.68x

Revenue (TTM)

FENC$59M

IRD$10M

Revenue Growth (YoY)

FENC77.8%

IRD-36.1%

Forward Rev Growth

FENC42.8%

IRD8.5%

Gross Margin (TTM)

FENC93.7%

IRD0.0%

Operating Margin (TTM)

FENC0.0%

IRD0.0%

EBITDA Margin (TTM)

FENC-1.9%

IRD-504.8%

Net Margin (TTM)

FENC-5.5%

IRD-1091.8%

FCF Margin (TTM)

FENC-3.4%

IRD-412.6%

Net Income (TTM)

FENC$-3M

IRD$-108M

FCF (TTM)

FENC$-2M

IRD$-41M

EPS (TTM)

FENC-$0.09

IRD-$1.13

ROE (TTM)

FENC-678.0%

IRD-31635.0%

ROA (TTM)

FENC-486.0%

IRD-17489.0%

ROIC (TTM)

FENC-678.0%

IRD-30100.0%

Cash

FENC$41M

IRD$89M

Debt

FENC$0

IRD$36M

Net Cash/Debt

FENC$41M

IRD$53M

Current Ratio (TTM)

FENC5.85x

IRD12.19x

Quick Ratio (TTM)

FENC5.36x

IRD11.87x

Debt/Equity (TTM)

FENC0.00x

IRD0.07x

Debt/Assets (TTM)

FENC0.0%

IRD0.0%

Interest Coverage (TTM)

FENCN/A

IRDN/A

Net Debt/EBITDA (TTM)

FENC0.00x

IRD0.00x

Beta

FENC1.21

IRD0.77

52W Performance

FENC16.2%

IRD126.8%

YTD Performance

FENC39.5%

IRD119.3%

% from 52W High

FENC-19.2%

IRD-34.2%

% from 52W Low

FENC89.6%

IRD173.5%

Asset Turnover (TTM)

FENC0.89x

IRD0.16x

FCF Yield (TTM)

FENC-0.5%

IRD-10.6%

Earnings Yield (TTM)

FENC-0.9%

IRD-28.0%

Dividend Yield (TTM)

FENCN/A

IRDN/A

Rule of 40

FENC74.4

IRD-448.7

EV/GP/RG

FENC0.12

IRDN/A

Ticker research

View FENC research View IRD research

Metric	FENC Fennec Pharmaceuticals Inc	IRD Opus Genetics Inc
Market & Valuation
Market Cap	$372M	$384M
Enterprise Value	$331M	$331M
Price	$10.71	$4.65
P/E Ratio	N/A	N/A
P/S Ratio	6.28x	38.96x
EV/Sales	5.59x	33.62x
EV/EBITDA	111.97x	11.29x
P/B Ratio	8.43x	24.83x
P/FCF Ratio	N/A	N/A
EV/FCF	-162.16x	-8.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	18.55x	N/A
Forward P/S (NTM)	4.23x	28.68x
Revenue & Growth
Revenue (TTM)	$59M	$10M
Revenue Growth (YoY)	77.8%	-36.1%
Forward Rev Growth	42.8%	8.5%
Profitability
Gross Margin (TTM)	93.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-504.8%
Net Margin (TTM)	-5.5%	-1091.8%
FCF Margin (TTM)	-3.4%	-412.6%
Net Income (TTM)	$-3M	$-108M
FCF (TTM)	$-2M	$-41M
EPS (TTM)	-$0.09	-$1.13
ROE (TTM)	-678.0%	-31635.0%
ROA (TTM)	-486.0%	-17489.0%
ROIC (TTM)	-678.0%	-30100.0%
Financial Health
Cash	$41M	$89M
Debt	$0	$36M
Net Cash/Debt	$41M	$53M
Current Ratio (TTM)	5.85x	12.19x
Quick Ratio (TTM)	5.36x	11.87x
Debt/Equity (TTM)	0.00x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.77
52W Performance	16.2%	126.8%
YTD Performance	39.5%	119.3%
% from 52W High	-19.2%	-34.2%
% from 52W Low	89.6%	173.5%
Efficiency & Yields
Asset Turnover (TTM)	0.89x	0.16x
FCF Yield (TTM)	-0.5%	-10.6%
Earnings Yield (TTM)	-0.9%	-28.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	74.4	-448.7
EV/GP/RG	0.12	N/A
Ticker research	View FENC research	View IRD research

Valuation

P/S Ratio

FENC

6.28x

IRD

38.96x

EV/FCF

FENC

-162.16x

IRD

-8.15x

Growth & revenue

Revenue Growth TTM

FENC

77.8%

IRD

-36.1%

Forward Revenue Growth

FENC

42.8%

IRD

8.5%

Profitability & performance

Gross Margin

FENC

93.7%

IRD

0.0%

ROE

FENC

-678.0%

IRD

-31635.0%

FCF Yield %

FENC

-0.5%

IRD

-10.6%

52-Week Performance

IRD

126.8%

FENC

16.2%

Detailed metrics comparison

FENC

Fennec Pharmaceuticals Inc

IRD

Opus Genetics Inc

Market Cap

FENC$372M

IRD$384M

Enterprise Value

FENC$331M

IRD$331M

Price

FENC$10.71

IRD$4.65

P/E Ratio

FENCN/A

IRDN/A

P/S Ratio

FENC6.28x

IRD38.96x

EV/Sales

FENC5.59x

IRD33.62x

EV/EBITDA

FENC111.97x

IRD11.29x

P/B Ratio

FENC8.43x

IRD24.83x

P/FCF Ratio

FENCN/A

IRDN/A

EV/FCF

FENC-162.16x

IRD-8.15x

PEG Ratio

FENCN/A

IRDN/A

Forward P/E (NTM)

FENC18.55x

IRDN/A

Forward P/S (NTM)

FENC4.23x

IRD28.68x

Revenue (TTM)

FENC$59M

IRD$10M

Revenue Growth (YoY)

FENC77.8%

IRD-36.1%

Forward Rev Growth

FENC42.8%

IRD8.5%

Gross Margin (TTM)

FENC93.7%

IRD0.0%

Operating Margin (TTM)

FENC0.0%

IRD0.0%

EBITDA Margin (TTM)

FENC-1.9%

IRD-504.8%

Net Margin (TTM)

FENC-5.5%

IRD-1091.8%

FCF Margin (TTM)

FENC-3.4%

IRD-412.6%

Net Income (TTM)

FENC$-3M

IRD$-108M

FCF (TTM)

FENC$-2M

IRD$-41M

EPS (TTM)

FENC-$0.09

IRD-$1.13

ROE (TTM)

FENC-678.0%

IRD-31635.0%

ROA (TTM)

FENC-486.0%

IRD-17489.0%

ROIC (TTM)

FENC-678.0%

IRD-30100.0%

Cash

FENC$41M

IRD$89M

Debt

FENC$0

IRD$36M

Net Cash/Debt

FENC$41M

IRD$53M

Current Ratio (TTM)

FENC5.85x

IRD12.19x

Quick Ratio (TTM)

FENC5.36x

IRD11.87x

Debt/Equity (TTM)

FENC0.00x

IRD0.07x

Debt/Assets (TTM)

FENC0.0%

IRD0.0%

Interest Coverage (TTM)

FENCN/A

IRDN/A

Net Debt/EBITDA (TTM)

FENC0.00x

IRD0.00x

Beta

FENC1.21

IRD0.77

52W Performance

FENC16.2%

IRD126.8%

YTD Performance

FENC39.5%

IRD119.3%

% from 52W High

FENC-19.2%

IRD-34.2%

% from 52W Low

FENC89.6%

IRD173.5%

Asset Turnover (TTM)

FENC0.89x

IRD0.16x

FCF Yield (TTM)

FENC-0.5%

IRD-10.6%

Earnings Yield (TTM)

FENC-0.9%

IRD-28.0%

Dividend Yield (TTM)

FENCN/A

IRDN/A

Rule of 40

FENC74.4

IRD-448.7

EV/GP/RG

FENC0.12

IRDN/A

Ticker research

View FENC research View IRD research

Metric	FENC Fennec Pharmaceuticals Inc	IRD Opus Genetics Inc
Market & Valuation
Market Cap	$372M	$384M
Enterprise Value	$331M	$331M
Price	$10.71	$4.65
P/E Ratio	N/A	N/A
P/S Ratio	6.28x	38.96x
EV/Sales	5.59x	33.62x
EV/EBITDA	111.97x	11.29x
P/B Ratio	8.43x	24.83x
P/FCF Ratio	N/A	N/A
EV/FCF	-162.16x	-8.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	18.55x	N/A
Forward P/S (NTM)	4.23x	28.68x
Revenue & Growth
Revenue (TTM)	$59M	$10M
Revenue Growth (YoY)	77.8%	-36.1%
Forward Rev Growth	42.8%	8.5%
Profitability
Gross Margin (TTM)	93.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-504.8%
Net Margin (TTM)	-5.5%	-1091.8%
FCF Margin (TTM)	-3.4%	-412.6%
Net Income (TTM)	$-3M	$-108M
FCF (TTM)	$-2M	$-41M
EPS (TTM)	-$0.09	-$1.13
ROE (TTM)	-678.0%	-31635.0%
ROA (TTM)	-486.0%	-17489.0%
ROIC (TTM)	-678.0%	-30100.0%
Financial Health
Cash	$41M	$89M
Debt	$0	$36M
Net Cash/Debt	$41M	$53M
Current Ratio (TTM)	5.85x	12.19x
Quick Ratio (TTM)	5.36x	11.87x
Debt/Equity (TTM)	0.00x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.77
52W Performance	16.2%	126.8%
YTD Performance	39.5%	119.3%
% from 52W High	-19.2%	-34.2%
% from 52W Low	89.6%	173.5%
Efficiency & Yields
Asset Turnover (TTM)	0.89x	0.16x
FCF Yield (TTM)	-0.5%	-10.6%
Earnings Yield (TTM)	-0.9%	-28.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	74.4	-448.7
EV/GP/RG	0.12	N/A
Ticker research	View FENC research	View IRD research